European Commission Grants Orphan Medicinal Product Designation to Karyopharm and Menarini Group

The European Commission has granted Orphan Medicinal Product Designation to Karyopharm Therapeutics Inc., a pharmaceutical company pioneering cancer therapies, and Menarini Group, a leading international pharmaceutical company, for selinexor used to treat myelofibrosis (MF). Selinexor was granted the orphan drug designation by the US Food and Drug Administration (FDA) in May 2022. Selinexor is currently […]

Continue Reading

EvaClean, ADYTON MedTech Partner to Provide Disinfection Solutions to Healthcare Facilities in Europe

EvaClean EU Ltd. and ADYTON MedTech, a healthcare technologies company in central and eastern Europe, have partnered to provide enhanced disinfection solutions to the healthcare facilities in central and eastern regions of Europe. Marek Jaluvka, chief business development and new partnerships officer at ADYTON MedTech, said their goal is to improve the lives of people […]

Continue Reading